✦ LIBER ✦

P.2.c.030 The COX-2 inhibitor celecoxib has therapeutic effects in major depression:results of a double-blind, placebo controlled, add-on study to reboxetine

✍ Scribed by M.J. Schwarz; S. Dehning; A. Douhe; A. Cerovecki; B. Goldstein-Müller; I. Spellmann; G. Hetzel; K. Maino; H.J. Möller; V. Arolt; M. Riedel; N. Müller

Book ID: 118592786
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 61 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70364-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cyclooxygenase-2 inhibitor celecoxib

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

✍ Müller, N; Schwarz, M J; Dehning, S; Douhe, A; Cerovecki, A; Goldstein-Müller, B 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Efficacy and safety of adding the dipept

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

✍ M. A. Nauck; G. C. Ellis; P. R. Fleck; C. A. Wilson; Q. Mekki; for the Aloglipti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB